Day Zero Diagnostics
Nicole Billings has extensive experience in the field of microbiology and microscopy. Nicole has held various roles in reputable organizations such as Day Zero Diagnostics, Inc, Draper Laboratory, and Massachusetts Institute of Technology. With a background in biomedical engineering, Nicole has conducted innovative research projects focusing on protein-protein interactions and nanoscale remodeling of microbial components. Nicole's academic achievements include a PhD in Microbiology from the University of Tennessee and a BS in Biology from Tennessee Wesleyan University. At Schering Plough Pharmaceuticals, Nicole served as a Quality Control Chemist.
Day Zero Diagnostics
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.